Show simple item record

Authordc.contributor.authorCastillo SM, Cesar del 
Authordc.contributor.authorCabrera Contreras, María Elena 
Authordc.contributor.authorDerio P., Lea 
Authordc.contributor.authorGaete V., Fancy 
Authordc.contributor.authorCavada Chacón, Gabriel 
Admission datedc.date.accessioned2018-05-14T16:50:30Z
Available datedc.date.available2018-05-14T16:50:30Z
Publication datedc.date.issued2017
Cita de ítemdc.identifier.citationRev Med Chile 2017; 145: 1507-1513es_ES
Identifierdc.identifier.issn0717-6163
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/147698
Abstractdc.description.abstractBackground: Breast cancer is the most common malignant tumor in women in the world. In 2005, it was incorporated to the Explicit Guaranties Health System (GES) in Chile. Aim: To describe the demographic and clinical characteristics of breast cancer patients and to determine the effect of incorporating these women to GES. Material and Methods: Medical records of 5,119 women with breast cancer aged 59 ± 14 years, attended at six public hospitals between 2000 and 2010 were reviewed. Median follow up was 87 months (range 1-182). Mortality was assessed using death certificates obtained at the National Identification Registry. Results: Sixty six percent of women were in stage I-II, 29% in stage III and 5% in stage IV. Surgery was performed in 4023/5119 cases (79%), adyuvant radiotherapy in 3627/4517 cases (80%), chemotherapy in 3,204/3,424 cases (94%) and hormone therapy in 1,695/2,375 cases (71%). Between 2000 and 2010, there was a significant increase in the proportion of cases in stage I, from 8% to 25%, (p < 0.01). Overall survival (OS) increased 1% per year, since the beginning of GES system (p = 0.024). Five year OS was 75.1%. The figures for Stage I, II, III and IV were 93, 84, 62 and 27% respectively (p < 0.01). Patients without lymph node involvement and who were not triple negative, had a significantly better OS. Conclusions: There was a significant increase in stage I cases, and a 1% per year OS improvement after GES system started, compared with the previous period.es_ES
Lenguagedc.language.isoeses_ES
Publisherdc.publisherSociedad Médica Santiagoes_ES
Type of licensedc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile*
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/*
Sourcedc.sourceRevista Médica de Chilees_ES
Keywordsdc.subjectBreast Neoplasmes_ES
Keywordsdc.subjectChilees_ES
Keywordsdc.subjectTherapeuticses_ES
Keywordsdc.subjectTriple Negative Breast Neoplasmes_ES
Títulodc.titleResultados del tratamiento del cáncer de mama, Programa Nacional de Cáncer del Adultoes_ES
Title in another languagedc.title.alternativeImpact of the Chilean Explicit Guaranties Health System (GES) on breast cancer treatmentes_ES
Document typedc.typeArtículo de revista
Catalogueruchile.catalogadortjnes_ES
Indexationuchile.indexArtículo de publicación ISIes_ES


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Chile
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile